COG stock news
This page provides real-time market news, earnings updates, and company announcements related to Cambridge Cognition Holdings Plc (COG).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-09 12:13 GMT
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-02 21:09:41
Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates
Finviz2026-03-02 21:09:42
Akamai to Deploy Thousands of NVIDIA Blackwell GPUs to Create One of the World's Most Widely Distributed AI Platforms
Finviz2026-03-03 11:33:47
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
Finviz2026-03-03 12:33:14
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-03-03 13:03:53
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Finviz2026-03-03 13:36:08
Vericel to Present at Multiple Upcoming Investor Conferences
Finviz2026-03-03 13:36:08
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-03 21:33:40
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Finviz2026-03-03 22:03:11
CDT Positions for Transformational Growth
Finviz2026-03-04 13:33:42
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
Akamai Discloses Technical Details on AI Cluster Deal
Finviz2026-03-05 11:33:03
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
Finviz2026-03-05 13:36:59
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
Finviz2026-03-05 13:33:09
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Finviz2026-03-05 21:12:18
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
CAMP4 to Participate in Upcoming Investor Conferences
Finviz2026-03-06 21:09:45
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Finviz2026-03-09 11:03:50
Editas: Fourth Quarter Financial Overview
101 finance2026-03-09 11:21:43
Korro Announces Oversubscribed $85 Million Private Placement
Finviz2026-03-09 11:33:52
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
Finviz2026-03-03 13:03:53
Prime Medicine Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-03 13:03:52
Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference
Finviz2026-03-03 13:36:08
Vericel to Present at Multiple Upcoming Investor Conferences
Finviz2026-03-03 13:36:08
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Finviz2026-03-03 21:09:41
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-03 21:33:40
Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duvakitug
Finviz2026-03-03 22:03:11
CDT Positions for Transformational Growth
Finviz2026-03-04 13:33:42
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Finviz2026-03-04 22:09:07
Akamai Discloses Technical Details on AI Cluster Deal
Finviz2026-03-05 11:33:03
CDT Equity Notes Sarborg Filing of U.S. Provisional Patent Application for AI Signature Agent
Finviz2026-03-05 13:36:59
Wave Life Sciences Announces Acceptance of Late-Breaking Oral Presentation on WVE-006 for Alpha-1 Antitrypsin Deficiency at the American Thoracic Society International Conference
Finviz2026-03-05 13:33:09
CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights
Finviz2026-03-05 21:12:18
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-03-06 21:06:48
CAMP4 to Participate in Upcoming Investor Conferences
Finviz2026-03-06 21:09:45
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
Finviz2026-03-09 11:03:50
Editas: Fourth Quarter Financial Overview
101 finance2026-03-09 11:21:43
Korro Announces Oversubscribed $85 Million Private Placement
Finviz2026-03-09 11:33:52
COG stock price change
On the last trading day, COG stock closed at 41.00 GBP, with a price change of 0.00% for the day.
Trade stock perpsCOG stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more